MOLECULAR MECHANISMS OF ACQUIRED RESISTANCE TO KINASE INHIBITORS

被引：0
|
作者：
Sequist, L. V. [1 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [31] Comprehensive molecular characterization of mechanisms involved in primary resistance to EGFR tyrosine kinase inhibitors
    Coya, Juan Manuel
    Alvarez, Eva
    Gomez-Sanchez, David
    Rosado, Aranzazu
    Ferrer, Irene
    Paz-Ares, Luis
    CANCER RESEARCH, 2022, 82 (12)
  • [32] Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibitors
    Geier, C.
    Posch, M. G.
    Dietz, R.
    Garratt, A. N.
    Oezcelik, C.
    KARDIOLOGE, 2007, 1 (03): : 209 - 215
  • [33] Acquired resistance to tyrosine kinase inhibitors during cancer therapy
    Engelman, Jeffrey A.
    Settleman, Jeffrey
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (01) : 73 - 79
  • [34] THE ROLE OF AXL IN ACQUIRED RESISTANCE TO EGFR TYROSINE KINASE INHIBITORS
    Lee, Jae Cheol
    Jang, Se Jin
    Choi, Chang-Min
    Kim, Kyu-Pyo
    Lee, Dae-Ho
    Kim, Sang-We
    Lee, Jung-Shin
    Kim, Woo Sung
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S678 - S678
  • [35] Cytomorphologic and Molecular Evolution of EGFR-Mutated Lung Adenocarcinomas with Acquired Resistance to Tyrosine Kinase Inhibitors
    Doxtader, Erika E.
    Brainard, Jennifer A.
    Sturgis, Charles D.
    Velcheti, Vamsidar
    Zhang, Yaxia
    LABORATORY INVESTIGATION, 2017, 97 : 93A - 93A
  • [36] Cytomorphologic and Molecular Evolution of EGFR-Mutated Lung Adenocarcinomas with Acquired Resistance to Tyrosine Kinase Inhibitors
    Doxtader, Erika E.
    Brainard, Jennifer A.
    Sturgis, Charles D.
    Velcheti, Vamsidar
    Zhang, Yaxia
    MODERN PATHOLOGY, 2017, 30 : 93A - 93A
  • [37] Mechanisms of intrinsic and acquired resistance to kinase-targeted therapies
    Bagrodia, Shubha
    Smeal, Tod
    Abraham, Robert T.
    PIGMENT CELL & MELANOMA RESEARCH, 2012, 25 (06) : 819 - 831
  • [38] Mechanisms of acquired resistance to ALK/ROS1 inhibitors
    Shaw, Alice T.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [39] Mechanisms of resistance to BCR--ABL kinase inhibitors
    Diamond, Joana M.
    Melo, Junia V.
    LEUKEMIA & LYMPHOMA, 2011, 52 : 12 - 22
  • [40] Mechanisms of Resistance to BCR-ABL Kinase Inhibitors
    Diamond, Joana
    da Silva, Maria Gomes
    ACTA MEDICA PORTUGUESA, 2013, 26 (04): : 402 - 408
12345